Stocks
Haemonetics Corporation (HAE) EBITDA US GAAP (year values) |
|||||||||
| 2023 | 2024 | 2024 | 2025 | 2026 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 252.0 | 295.5 | 356.0 | 397.1 | 337.6 | |||
| Changes by years, y/y, % | +1% | -100% | +20% | +12% | +16.6% | ||||
Haemonetics Corporation. EBITDA US GAAP, bln rub
Haemonetics Corporation. EBITDA US GAAP, changes, %
Haemonetics Corporation. EBITDA US GAAP, sum by quarters, bln rub
Haemonetics Corporation (HAE) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | 2026Q4 | LTM ? | |||
| EBITDA, bln rub | ? | 79.7 | 93.7 | 95.5 | 96.9 | 51.4 | 337.6 | |
| Changes by years, y/y, % | +16% | +17% | +7% | +2% | -35% | |||
| Changes by quarters, q/q, % | -16% | +18% | +2% | +1% | -47% | |||
